1 – 20 of 30
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Follicular Lymphoma : Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs
(
- Contribution to journal › Article
- 2016
-
Mark
Drug utilization research in the area of cancer drugs
2016) p.315-327(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
(
- Contribution to journal › Article
-
Mark
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
(
- Contribution to journal › Article
- 2014
-
Mark
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors
(
- Contribution to journal › Article
- 2012
-
Mark
Oleic acid is a key cytotoxic component of HAMLET-like complexes
(
- Contribution to journal › Article
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
(
- Contribution to journal › Article
- 2011
-
Mark
A novel method for preparation of HAMLET-like protein complexes
(
- Contribution to journal › Article
-
Mark
The role of RANK-ligand inhibition in cancer : the story of denosumab
(
- Contribution to journal › Scientific review
-
Mark
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
(
- Contribution to journal › Article
-
Mark
Discovery of a novel B-Raf fusion protein related to c-Met drug resistance
(
- Contribution to journal › Article
-
Mark
MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells
(
- Contribution to journal › Article
-
Mark
Global microRNA analysis of the NCI-60 cancer cell panel
(
- Contribution to journal › Article
- 2009
-
Mark
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
(
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
(
- Contribution to journal › Article
- 2008
-
Mark
Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil
(
- Contribution to journal › Article
-
Mark
Role of homologous recombination in trabectedin-induced DNA damage
(
- Contribution to journal › Article